Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_assertion type Assertion NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_head.
- NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_assertion description "[In conclusion, our data, for the first time, demonstrate that MCT1 inhibition has antitumor potential which is associated with the NF-?B pathway, and high MCT1 expression predicates poor overall survival in patients with osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_provenance.
- NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_assertion evidence source_evidence_literature NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_provenance.
- NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_assertion SIO_000772 24012639 NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_provenance.
- NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_assertion wasDerivedFrom befree-2016 NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_provenance.
- NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_assertion wasGeneratedBy ECO_0000203 NP1108317.RAmWbuO6F1Kdciv_6jVJa0BvvwZ8M9bfmHFXmEHWBkVi8130_provenance.